VIENNA — Ursula Schmidt-Erfurth, MD, introduces the scientific program of the annual Advanced Retinal Therapy meeting, which this year has a focus on OCT angiography as well as on the role of anti-VEGF in treating proliferative diabetic retinopathy.
(MedPage Today) — Should self-insured employers be required to furnish data to states?
Triple combination therapy for neovascular age-related macular degeneration was more cost-effective and dosed less frequently with supplemental zeaxanthin than without the supplement, according to a study.The comparative interventional study included 5…
PARIJS–(BUSINESS WIRE)–Sofinnova Partners, een toonaangevende durfinvesteerder in de levenswetenschappen, heeft vandaag bekendgemaakt dat het fonds Sofinnova Capital VIII is afgesloten met 300 miljoen euro. Daarmee is het streefbedrag van 250 miljoen…
PARIGI–(BUSINESS WIRE)–Sofinnova Partners, importante operatore europeo di venture capital specializzato nel settore delle bioscienze, ha oggi annunciato la chiusura di Sofinnova Capital VIII a 300 milioni di euro, in eccesso rispetto al target inizi…
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the first sale of the IOPtiMate system to a medical center located in Portugal.